Matthew Wanat to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Matthew Wanat has written about Randomized Controlled Trials as Topic.
Connection Strength
0.217
-
A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis. Heart Fail Rev. 2020 03; 25(2):207-216.
Score: 0.174
-
Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy. JAMA Cardiol. 2020 01 01; 5(1):111.
Score: 0.043